A carregar...
A hypothesis for pathobiology and treatment of COVID‐19: The centrality of ACE1/ACE2 imbalance
Angiotensin Converting Enzyme2 is the cell surface binding site for the coronavirus SARS‐CoV‐2, which causes COVID‐19. We propose that an imbalance in the action of ACE1‐ and ACE2‐derived peptides, thereby enhancing angiotensin II (Ang II) signalling is primary driver of COVID‐19 pathobiology. ACE1/...
Na minha lista:
| Publicado no: | Br J Pharmacol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7572451/ https://ncbi.nlm.nih.gov/pubmed/32333398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.15082 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|